Compare ENOV & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENOV | AIP |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | United States |
| Employees | 7802 | N/A |
| Industry | Fluid Controls | Semiconductors |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2008 | 2021 |
| Metric | ENOV | AIP |
|---|---|---|
| Price | $17.79 | $22.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | $37.58 | ★ $39.43 |
| AVG Volume (30 Days) | ★ 1.6M | 556.3K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $70,579,000.00 |
| Revenue This Year | $4.05 | $37.01 |
| Revenue Next Year | $4.89 | $20.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 22.27 |
| 52 Week Low | $16.70 | $12.06 |
| 52 Week High | $34.28 | $50.26 |
| Indicator | ENOV | AIP |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 43.19 |
| Support Level | $17.30 | $22.54 |
| Resistance Level | $18.79 | $23.63 |
| Average True Range (ATR) | 0.76 | 0.90 |
| MACD | 0.20 | 0.07 |
| Stochastic Oscillator | 43.72 | 17.19 |
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum its revenue from Asia Pacific.